Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
35 The impact of treatment modalities on use of ctDNA as ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
35 The impact of treatment modalities on use of ctDNA as an early endpoint in aNSCLC trials
0
Authors
Hillary Stires
20 more
Hillary Stires
•
Névine Zariffa
18 more
•
Jeff Allen
Published
November 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Regular and Young Investigator Award Abstracts
Topics
Medicine
Cancer Oncology
Internal Medicine
Cancer Research
Modalities
Show all topics
DOI
10.1136/jitc-2024-sitc2024.0035
License
CC-BY-NC
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Regular and Young Investigator Award Abstracts
Topics
Medicine
Cancer Oncology
Internal Medicine
Cancer Research
Modalities
Show all topics
DOI
10.1136/jitc-2024-sitc2024.0035
License
CC-BY-NC
Other Formats
PDF
